suggested that the combination treatment of cGAMP and anti-CD47 mAb induced effective anti-tumor immune responses through the activation of monocyte/macrophage phagocytosis and adaptive immune response, which relied on STING and type I IFN signaling. Here, CD47 is linked to neoplasm.